Comparison of Rituximab Induction Therapy Followed by Glatiramer Acetate

NCT01569451 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Rituximab
DRUG: Glatiramer Acetate
OTHER: Placebo

Sponsor

University of Colorado, Denver

Collaborators

[object Object]